Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
BioOptics Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Avicanna Inc
(OP:
AVCNF
)
0.2029
UNCHANGED
Streaming Delayed Price
Updated: 1:05 PM EST, Dec 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Avicanna Inc
< Previous
1
2
3
4
Next >
Avicanna Reduces Net Loss And Improves Gross Profit, Focusing On International Markets
November 15, 2024
Via
Benzinga
Cannabis Flower Sales In Colombia And The Small Producer Protection Myth: Ex-Official Says Most Companies Qualify
October 24, 2024
Colombia's cannabis decree allows dry flower sales, but ex-official claims it won't just protect small producers—most companies may qualify.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
CBD's Toxicity Concerns: Could Europe Ban Cannabidiol In Cosmetics?
September 23, 2024
CBD could be deemed toxic for reproduction, which would then lead to its prohibition in cosmetic products across Europe.
Via
Benzinga
Avicanna Secures Nearly $2M In Private Placement Deal Amid US Patent Win For Cannabinoid Topical Formula
August 29, 2024
Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) announced on Thursday that it has closed a non-brokered private placement offering of its 6,620,692 units at $0.30 per unit for aggregate gross...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Avicanna Secures US Patent For Topical Cannabinoid Technology To Treat Pain And Inflammation
August 27, 2024
Avicanna secures a U.S. patent for its innovative deep penetrating topical cannabinoid composition for treating pain and inflammation.
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Avicanna's CBG Products Reach 19 Countries: Denmark Joins Global Expansion
August 15, 2024
Avicanna Inc. (OTC: AVCNF) biopharmaceutical company announced Thursday the successful export of its Aureus-branded cannabigerol (CBG) products to Denmark.
Via
Benzinga
Avicanna Q2 Revenue Improves 85% YoY, Cannabis Company Touts Two Successful Trials On Drug Candidates
August 15, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Latest Cannabis Hires And Board Changes, Here's What You Need To Know
July 12, 2024
Cannabis ancillary company EnWave Corporation (TSX-V: ENW) (FSE: E4U) announced on Thursday that it had tapped Danna Dunnage as its new vice president of global sales and business development. Dunnage...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Avicanna Exports Cannabinoids To Singapore Legally — Even Though Cannabis Is Punishable By Death In The Country
July 11, 2024
Cannabinoid-focused biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) announced on Thursday that through its majority-owned subsidiary Santa Marta Golden Hemp the company...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
CBD-Focused Avicanna Reports First-Ever Adjusted EBITDA Positive Quarter, 451% YoY Spike In Q1 Record Revenue
May 14, 2024
Cannabis-focused biopharmaceutical company Avicanna Inc. announced on Tuesday financial results for the first quarter of fiscal 2024.CEO Aras Azadian called it its "best quarter." In addition to being...
Via
Benzinga
CBD Helps With This Rare Blistering Skin Disorder, New Study From Avicanna Shows Promising Results In Epidermolysis Bullosa Treatment
May 13, 2024
There is no cure for a rare blistering skin disorder called Epidermolysis Bullosa (EB). But, treatments to help alleviate and control the symptoms do exist. The growing body of research suggests...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabinoid-Based Products Maker Sees Triple-Digit Growth In 2023 Gross Profit, Revenue Surges 314% YoY
April 02, 2024
Cannabinoids-focused biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) reported on Tuesday year-end 2023 results and audited financial statements. The Canadian company...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
This Company Is Bringing Medical Marijuana Telehealth To Over Half The U.S.
March 01, 2024
MMJ.com, a telehealth platform providing access to medical marijuana, has expanded its services to 26 states. This expansion allows patients to consult state-certified doctors online for medical...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Can Cannabis Treat Severe Forms Of Epilepsy? New Medicine Sparks Hope As Colombia's Weed Industry Goes Global
February 14, 2024
Clever Leaves Holdings Inc.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
CBD-Focused Avicanna Taps Into European Market Via Exclusive Pharma Supply Deal
February 05, 2024
Canadian cannabinoid-based biopharmaceutical firm Avicanna will supply two proprietary topical products to an unnamed multinational pharmaceutical firm in six European countries in 2024. The deal will...
Via
Benzinga
CBD-Focused Avicanna Announces Funding Boost For Research And Development
December 05, 2023
Cannabinoid-based biopharmaceutical company Avicanna Inc.
Via
Benzinga
Avicanna Inc.: Medical Marijuana Sales Reach Record 713% YoY Growth In Q3, Introduces New Platform
November 14, 2023
Avicanna Inc. (OTCQX: AVCNF) a biopharmaceutical company specializing in proprietary cannabinoid-based products, announced Q3 2023 results late Tuesday, highlighted by the successful acquisiti
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From August 25, 2023
August 25, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Marijuana Stock Movers For August 23, 2023
August 23, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Bullish Thursday For Marijuana Stocks - EVIO, Tetra Bio Pharma Among Top Gainers
August 17, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Canadian Cannabis Producer Reports Revenue Spike And Improved Margins In Q2, But What About Net Loss?
August 15, 2023
Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) announced reported its interim second-quarter financial statements for the three months ending June 30, 2023.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Bearish Monday For Marijuana Stocks - EVIO, Item 9 Labs Among Top Gainers
August 07, 2023
Via
Benzinga
Cannabis Stock Gainers And Losers From August 16, 2023
August 16, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
This Cannabis Company Just Launched Medical Marijuana Care Platform And Finalized Important Acquisition
August 01, 2023
Avicanna Inc.
Via
Benzinga
Cannabis Stock Movers For August 10, 2023
August 10, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Avicanna Reveals The Initial Network Of Brands On Its Cannabis Care Platform
July 28, 2023
Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN) a biopharmaceutical company focused on the development, manufacturing and commercialisation of plant-derived cannabinoid-based products announced its...
Via
Benzinga
Cannabis Stock Gainers And Losers From July 25, 2023
July 25, 2023
Via
Benzinga
Marijuana Stock Movers For August 8, 2023
August 08, 2023
Via
Benzinga
Cannabis Stock Gainers And Losers From August 4, 2023
August 04, 2023
Via
Benzinga
Marijuana Stock Movers For July 31, 2023
July 31, 2023
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.